INTERNATIONAL PATENT: AVIDENCE THERAPEUTICS, INC. FILES APPLICATION FOR "MICROSPHERE-BASED INJECTABLE FINASTERIDE FORMULATION"

GENEVA, Nov. 11 -- AVIDENCE THERAPEUTICS, INC. (423 West 127th StreetNew York, New York 10027) filed a patent application (PCT/US2025/026343) for "MICROSPHERE-BASED INJECTABLE FINASTERIDE FORMULATION" on Apr 25, 2025. With publication no. WO/2025/230821, the details related to the patent application was published on Nov 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LI, Ang (363 West 123rd Street, Apt. 1RNew York, New York 10027)

Abstract: This invention provides a plurality of biodegradable microspheres, wherein the microspheres (i) have a d10 value of at least 1 Mum and a d90 value o...